021-51111890
购物车（）
sales@molnova.cn
mTOR inhibitor 9b
CAS No. 1144075-34-2
mTOR inhibitor 9b ( —— )
产品货号. M35931 CAS No. 1144075-34-2
mTOR inhibitor 9b is an enzyme inhibitor of protein kinase mTOR he phosphatidylinositol 3-kinase PIK3CA with IC50s of 0.76 nm and 1.262 μM, respectively.mTOR inhibitor 9b possesses anticancer activity and can be used to study leukemia, skin, breast, lung and colon cancers.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2233 | 有现货 |
|
| 10MG | ￥3097 | 有现货 |
|
| 25MG | ￥4371 | 有现货 |
|
| 50MG | ￥5385 | 有现货 |
|
| 100MG | ￥6615 | 有现货 |
|
| 200MG | ￥8757 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称mTOR inhibitor 9b
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述mTOR inhibitor 9b is an enzyme inhibitor of protein kinase mTOR he phosphatidylinositol 3-kinase PIK3CA with IC50s of 0.76 nm and 1.262 μM, respectively.mTOR inhibitor 9b possesses anticancer activity and can be used to study leukemia, skin, breast, lung and colon cancers.
-
产品描述mTOR inhibitor 9b is an enzyme inhibitor of protein kinase mTOR he phosphatidylinositol 3-kinase PIK3CA with IC50s of 0.76 nm and 1.262 μM, respectively.mTOR inhibitor 9b possesses anticancer activity and can be used to study leukemia, skin, breast, lung and colon cancers.
-
体外实验——
-
体内实验——
-
同义词——
-
通路PI3K/Akt/mTOR signaling
-
靶点mTOR
-
受体mTOR
-
研究领域——
-
适应症——
化学信息
-
CAS Number1144075-34-2
-
分子量409.5
-
分子式C21H23N5O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESN(C(NCC)=O)C1=CC=C(C2=NC(=C3C(=N2)C=CS3)N4CC5OC(C4)CC5)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
DMH-25
DMH25是一种新型共价有效的mTOR抑制剂，对三阴性乳腺癌细胞表现出体内抗肿瘤活性。在体内，DHM25是三阴性乳腺癌细胞生长和转移的有效抑制剂，为其临床应用铺平了道路。在肿瘤学中的应用。
-
PRT-060318
PRT-060318 (PRT318) 是一种新型选择性 Syk 酪氨酸激酶抑制剂，可作为 HIT 治疗的一种方法。
-
RapaLink-1
RapaLink-1 是第三代 mTOR 抑制剂，克服了现有第一代和第二代抑制剂的耐药性。
